Ozben, T. Et Al. 2005. Tumour necrosis factor-alpha, interleukin-6, and fasting serum insulin correlate with clinical outcome in metastatic breast cancer patients treated with chemotherapy. European Congress of Clinical Biochemistry and Laboratory Medicine (EUROMEDLAB 2005) , (Glasgow, United Kingdom).

Ozben, T., Bozcuk, H., Uslu, G., & Akan, I., (2005). Tumour necrosis factor-alpha, interleukin-6, and fasting serum insulin correlate with clinical outcome in metastatic breast cancer patients treated with chemotherapy . European Congress of Clinical Biochemistry and Laboratory Medicine (EUROMEDLAB 2005), Glasgow, United Kingdom

Ozben, T Et Al. "Tumour necrosis factor-alpha, interleukin-6, and fasting serum insulin correlate with clinical outcome in metastatic breast cancer patients treated with chemotherapy," European Congress of Clinical Biochemistry and Laboratory Medicine (EUROMEDLAB 2005), Glasgow, United Kingdom, 2005

Ozben, T Et Al. "Tumour necrosis factor-alpha, interleukin-6, and fasting serum insulin correlate with clinical outcome in metastatic breast cancer patients treated with chemotherapy." European Congress of Clinical Biochemistry and Laboratory Medicine (EUROMEDLAB 2005) , Glasgow, United Kingdom, 2005

Ozben, T. Et Al. (2005) . "Tumour necrosis factor-alpha, interleukin-6, and fasting serum insulin correlate with clinical outcome in metastatic breast cancer patients treated with chemotherapy." European Congress of Clinical Biochemistry and Laboratory Medicine (EUROMEDLAB 2005) , Glasgow, United Kingdom.

@conferencepaper{conferencepaper, author={T Ozben Et Al. }, title={Tumour necrosis factor-alpha, interleukin-6, and fasting serum insulin correlate with clinical outcome in metastatic breast cancer patients treated with chemotherapy}, congress name={European Congress of Clinical Biochemistry and Laboratory Medicine (EUROMEDLAB 2005)}, city={Glasgow}, country={United Kingdom}, year={2005}}